Testicular tumors: discriminative value of conventional MRI and diffusion weighted imaging
- PMID: 35049179
- PMCID: PMC9191385
- DOI: 10.1097/MD.0000000000027799
Testicular tumors: discriminative value of conventional MRI and diffusion weighted imaging
Abstract
To explore the feasibility of using conventional MRI features combined with apparent diffusion coefficient (ADC) values for the differential diagnosis of testicular tumors.A total of 63 patients with pathologically confirmed testicular tumors were enrolled in this study. In particular, there were 46 cases of malignant lesions and 17 cases of benign lesions. All patients underwent conventional magnetic resonance imaging (MRI) and diffusion weighted imaging. Multivariate logistic regression models and receiver operating characteristic curves were constructed to assess diagnostic accuracies.T2-homogeneity, intratumoral septa, and peritumoral infiltration were more common in the malignant group, and capsule sign was more common in the benign group (P < .05 for all). The mean ADC value of the malignant group was lower than that of the benign group (P < .05). When the ADC value ≤ 0.90 × 10-3 mm2/s, the diagnosis tended to be malignancy. The conventional MRI model could achieve better diagnostic accuracy than ADC values alone (P < .05). Compared with the conventional MRI model, the specificity and accuracy of the full model (ADC and conventional MRI model) increased by 9.8% and 3.2%, respectively. T2-homogeneity and T2-hypointensity were more common in seminoma and lymphoma, cystic changes were more common in nonseminomatous germ cell tumor (NSGCT), and intratumoral septa was more common in seminoma (P < .05 for all). The ADC value of NSGCT was larger than seminoma, and lymphoma was the smallest (P < .05 for all). Cystic changes, T2-hypointensity, intratumoral septa, and ADC value were independent factors for differentiating the seminoma, NSGCT, and lymphoma subgroups.A combination of conventional MRI features and ADC values can improve the diagnostic efficiency for differentiating benign and malignant testicular tumors, and can additionally distinguish different subtypes of malignant testicular tumors.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures
References
-
- Albers P, Albrecht W, Algaba F, et al. . EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011;60:304–19. - PubMed
-
- Oldenburg J, Fosså SD, Nuver J, et al. . Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24: (Suppl 6): vi125–32. - PubMed
-
- Vitolo U, Chiappella A, Ferreri AJ, et al. . Firstline treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. J Clin Oncol 2011;29:2766. - PubMed
-
- Gomez A, Santana PC, Mouro AP. Dosimetry study in head and neck of anthropomorphic phantoms in computed tomography scans. SciMed J 2020;2:38–43.
-
- Thomas LJ, Brooks MA, Stephenson AJ. The role of imaging in the diagnosis, staging, response to treatment, and surveillance of patients with germ cell tumors of the testis. Urol Clin North Am 2019;46:315–31. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
